AAAAAA
Results:
1-7
|
Results: 7
Authors:
CHEN VJ
BEWLEY JR
ANDIS SL
SCHULTZ RM
IVERSEN PW
SHIH C
MENDELSOHN LG
SEITZ DE
TONKINSON JL
Citation: Vj. Chen et al., PRECLINICAL CELLULAR PHARMACOLOGY OF LY231514 (MTA) - A COMPARISON WITH METHOTREXATE, LY309887 AND RALTITREXED FOR THEIR EFFECTS ON INTRACELLULAR FOLATE AND NUCLEOSIDE TRIPHOSPHATE POOLS IN CCRF-CEM CELLS, British Journal of Cancer, 78, 1998, pp. 27-34
Authors:
CHEN VJ
BEWLEY JR
ANDIS SL
SCHULTZ RM
SHIH C
MENDELSOHN LG
SEITZ DE
TONKINSON JL
Citation: Vj. Chen et al., EFFECTS OF MTA (MULTITARGETED ANTIFOLATE, LY231514) ON INTRACELLULAR FOLATE AND NUCLEOSIDE TRIPHOSPHATE POOLS IN CCRF-CEM CELLS, European journal of cancer, 33, 1997, pp. 803-803
Authors:
VERMORKEN JB
GUASTALLA JP
HATTY SR
SEITZ DE
TANIS B
MCDANIELS C
CLAVEL MD
Citation: Jb. Vermorken et al., PHASE-I STUDY OF GEMCITABINE USING A ONCE EVERY 2 WEEKS SCHEDULE, British Journal of Cancer, 76(11), 1997, pp. 1489-1493
SYNTHESIS AND CHEMICAL-PROPERTIES OF A SERIES OF DOXORUBICIN ENAMINOMALONYL-BETA-ALANINE DERIVATIVES
Authors:
SEITZ DE
EZCURRA JE
GUTTMAN DL
Citation: De. Seitz et al., SYNTHESIS AND CHEMICAL-PROPERTIES OF A SERIES OF DOXORUBICIN ENAMINOMALONYL-BETA-ALANINE DERIVATIVES, Tetrahedron letters, 36(9), 1995, pp. 1413-1416
Authors:
SEITZ DE
Citation: De. Seitz, TRIMETREXATE - A CRITICAL-APPRAISAL OF THE PHASE-II CLINICAL-TRIAL EXPERIENCE - EVIDENCE OF DRUG DISCOVERY CLINICAL DEVELOPMENT DISJUNCTION, Cancer investigation, 12(6), 1994, pp. 657-661
Authors:
SEITZ DE
Citation: De. Seitz, ONCOLOGY DRUG DISCOVERY AND CLINICAL-TRIAL TESTING - WHOS LISTENING -REPLY, Cancer investigation, 12(1), 1994, pp. 107-108
Authors:
MUNSHI NC
SEITZ DE
FOSSELLA F
LIPPMAN SM
EINHORN LH
Citation: Nc. Munshi et al., PHASE-II STUDY OF SULOFENUR (LY-186641) - A NOVEL ANTINEOPLASTIC AGENT IN ADVANCED NON-SMALL-CELL LUNG-CANCER, Investigational new drugs, 11(1), 1993, pp. 87-90
Risultati:
1-7
|